✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Xenon Pharmaceuticals Inc

Common Name
Xenon Pharmaceuticals
Country
Canada
Sector
Healthcare
Industry
Biotechnology
Employees
316
Ticker
XENE
Exchange
NASDAQ/NMS
Description
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. The primary functio...

Xenon Pharmaceuticals's Financial Statements Preview

Below are the financial statements of Xenon Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenue
0a
0a
9.43a
Operating expenses
Research and development
-210.39a
-167.51a
-105.77a
General and administrative
-68.9a
-46.54a
-32.81a
Loss from operations
-279.3a
-214.05a
-129.14a
Other income (expense)
Interest income
41.94a
27.62a
8.71a
Unrealized fair value gain (loss) on trading securities
0a
3.55a
-2.93a
Foreign exchange gain (loss)
-1.06a
0.2a
-1.89a
Loss before income taxes
-238.42a
-182.69a
-125.26a
Income tax recovery (expense)
4.09a
0.29a
-0.12a
Net loss
-234.33a
-182.39a
-125.37a
Net loss attributable to preferred shareholders
0a
0a
-0.44a
Net loss attributable to common shareholders
-234.33a
-182.39a
-124.94a
Limited Data Preview
You are viewing a limited preview of Xenon Pharmaceuticals’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Xenon Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Xenon Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Xenon Pharmaceuticals's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?